|
ZNF431 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.932600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.491600E-01 |
| Normal-vs-Stage2 |
3.558100E-02 |
| Normal-vs-Stage3 |
7.096400E-01 |
| Normal-vs-Stage4 |
4.956800E-01 |
| Stage1-vs-Stage2 |
3.078200E-02 |
| Stage1-vs-Stage3 |
5.457400E-01 |
| Stage1-vs-Stage4 |
3.547200E-01 |
| Stage2-vs-Stage3 |
6.154200E-02 |
| Stage2-vs-Stage4 |
1.282040E-01 |
| Stage3-vs-Stage4 |
7.449200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.254600E-01 |
| Normal-vs-AfricanAmerican |
4.183800E-01 |
| Normal-vs-Asian |
4.843400E-01 |
| Caucasian-vs-AfricanAmerican |
4.637200E-01 |
| Caucasian-vs-Asian |
4.544000E-01 |
| AfricanAmerican-vs-Asian |
2.893200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.277400E-01 |
| Normal-vs-Female |
9.914600E-01 |
| Male-vs-Female |
1.473760E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.968000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.012400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.395800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.620100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.067780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.751900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.618030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.907400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.797400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.466600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.480580E-01 |
| Classical-VS-Follicular |
4.32986979603811E-15 |
| Classical-VS-Other |
2.137400E-01 |
| Classical-VS-Normal |
1.063370E-01 |
| Tall-VS-Follicular |
3.58200000000197E-05 |
| Tall-VS-Other |
2.763400E-01 |
| Tall-VS-Normal |
9.683600E-01 |
| Follicular-VS-Other |
1.902450E-01 |
| Follicular-VS-Normal |
3.47630000008259E-07 |
| Other-VS-Normal |
2.656400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.050210E-01 |
| Normal-vs-N1 |
4.761600E-01 |
| N0-vs-N1 |
6.026100E-02 |
|
|
